MONDAY, Oct. 7, 2024 — Dupilumab improves health-related quality of life (HRQoL) in patients with chronic obstructive pulmonary disease (COPD) and type 2 inflammation, according to a study presented at CHEST 2024, the annual meeting of the American…Original Article
CHEST: Dupilumab for COPD Tied to Improvement in Health-Related Quality of Life
MONDAY, Oct. 7, 2024 — Dupilumab improves health-related quality of life (HRQoL) in patients with chronic obstructive pulmonary disease (COPD) and type 2 inflammation, according to a study presented at CHEST 2024, the annual meeting of the American…
